Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gallbladder01:17

Gallbladder

1.3K
The gallbladder is a small, pear-shaped organ that plays a crucial role in our digestive system. Measuring about 10 cm in length, it is comparable in size to a kiwi fruit and is located in a hollow area on the lower surface of the liver. The gallbladder's primary function is to store and concentrate bile, a fluid produced by the liver that aids in digestion.
The gallbladder's anatomy consists of three regions: the fundus, body, and neck. Extending from the neck, the cystic duct joins...
1.3K
Gastritis-I: Introduction and Types01:27

Gastritis-I: Introduction and Types

1.5K
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
1.5K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

14.9K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.9K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

836
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
836
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

726
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
726
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

2.4K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Evidence-based recommendations for diagnostics and treatment of gouty arthritis in the specialist sector : S2e guidelines of the German Society of Rheumatology in cooperation with the AWMF].

Zeitschrift fur Rheumatologie·2017
Same author

2016 updated EULAR evidence-based recommendations for the management of gout.

Annals of the rheumatic diseases·2016
Same author

Disabling gout.

Lancet (London, England)·2010
Same author

Ortner's syndrome or cardiovocal hoarseness.

Internal medicine journal·2007
Same author

[Hyperuricemia and gout: diagnosis and therapy].

Der Internist·2006
Same author

Anti-midbody antibodies as a possible predictive factor for a special limited or abortive form of systemic sclerosis?

Annals of the rheumatic diseases·2005
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Related Experiment Video

Updated: Nov 12, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.4K

[Gout].

A K Tausche1

  • 1Medizinische Klinik III, Rheumatologie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstr. 74, 01309, Dresden, Deutschland. anne-kathrin.tausche@uniklinikum-dresden.de.

Der Internist
|March 15, 2021
PubMed
Summary
This summary is machine-generated.

Gout, a common inflammatory arthritis caused by hyperuricemia, requires urate-lowering strategies to prevent joint damage and associated health risks. Effective diagnosis and treatment are crucial for managing this metabolic disease.

Keywords:
AllopurinolCrystal arthropathiesFebuxostatGout/comorbiditiesUric acid

More Related Videos

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril
10:02

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril

Published on: October 3, 2020

4.1K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.2K

Related Experiment Videos

Last Updated: Nov 12, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.4K
Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril
10:02

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril

Published on: October 3, 2020

4.1K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.2K

Area of Science:

  • Rheumatology
  • Metabolic Diseases
  • Epidemiology

Background:

  • Gout is the most prevalent inflammatory arthritis in men, with increasing global incidence.
  • It is a metabolic condition stemming from hyperuricemia, influenced by genetics, diet, aging, and medications.
  • Untreated hyperuricemia leads to urate crystal deposition, causing recurrent flares, joint destruction, and tophi, alongside increased cardiovascular mortality.

Purpose of the Study:

  • To summarize current knowledge on the diagnosis of gout.
  • To outline contemporary therapeutic strategies for gout management.
  • To emphasize the importance of urate-lowering treatments.

Main Methods:

  • Review of recent scientific literature on gout diagnosis and therapy.
  • Analysis of guidelines for managing hyperuricemia and gout flares.
  • Synthesis of information on comorbidities and mortality in gout patients.

Main Results:

  • Gout diagnosis relies on identifying urate crystal deposition.
  • Effective management involves lowering serum urate levels to below 360 µmol/l.
  • Silent inflammation can persist even in asymptomatic stages of gout.

Conclusions:

  • Consequent urate-lowering strategies are essential for gout management.
  • Addressing hyperuricemia prevents disease progression, joint damage, and reduces mortality.
  • Comprehensive management of gout includes treating comorbidities.